Symposium Summary
Technological advances in radiotherapy, often driven by engineers, enable us to redefine how we detect, treat and monitor cancer. New developments in genomics provide a path for strategizing patient treatment. The purpose of this catalyst conference is to bring together experts in these areas to highlight current state of the art in cancer precision radiotherapy treatment and monitoring, which will highlight opportunities for collaborations and formulate strategies for addressing critical questions in adaptive precision driven innovation.
The meeting is primarily intended for radiation oncologists, medical physicists, medical oncologists, cancer bioinformatics researchers, as well as therapists, dosimetrists and researchers interested in developing new approaches in precision radiation therapy. The purpose of this catalyst conference is to bring together experts in these areas to highlight opportunities for collaborations and formulate strategies for addressing critical questions in adaptive precision driven innovation.
Symposium Organizers
Ida Deichaite, PhD
Assistant Adjunct Professor, Radiation Medicine & Applied Sciences, Dir. Translational Programs, Moores Cancer Center, UC San Diego
Dr. Ida Deichaite oversees the translational aspects of oncology at UC San Diego Moores Cancer Center, turning innovation into commercial applications. Her successful partnering with pharma includes overseeing strategy and execution of translational alliances between academia and industry.
Dr. Deichaite is an Assistant Adjunct Professor in the Department of Radiation Medicine and Applied Sciences. Her research is focused on radiogenomics for personalizing radiation therapy to improve outcomes.
She is the Section Editor of Science Policy and Industry/Academia Interface of the Journal of Translational Medicine. Dr. Deichaite is widely published in numerous scientific journals. Dr. Deichaite received her Ph.D. from Princeton University, Master’s degree from the Weizmann Institute, and BA from Hebrew University.
Vitali Moiseenko, PhD
Professor, Radiation Medicine & Applied Sciences, UC San Diego
Dr. Vitali Moiseenko is a Professor and serves as Technology Service Chief for both the Genitourinary (GU) and Head/Neck Cancer Disease Teams. He also oversees a laboratory in the Center for Quality, Innovation, Value and Efficiency in Radiotherapy (QUIVER).
A research-focused Medical Physicist, his interests include outcomes data analysis, functional imaging, Monte Carlo simulations, propagation of uncertainties associated with radiation therapy and modeling of tumor and normal tissue response to radiation. He is the author of over 130 peer-reviewed journal articles, reviews and book chapters. He is also a dedicated educator and is involved with Medical Physics Residency Program. He has been named Teacher of the Year by our medical physics residents multiple times, recognizing his valuable contributions to their education and training.
Dr. Moiseenko serves on multiple national committees in the American Association of Physicists in Medicine (AAPM), including Task Group 256, Task Group 166, the Biologic Effects Sub-Committee, the Working Group on Biologic Effects of Hypofractionation and SBRT. He has also participated in multiple QUANTEC, HyTEC and PENTEC Committees and Reports.
Kevin Moore, PhD
Professor & Deputy Division Director of Medical Physics, Assistant Vice Chair for Physics and Technology Research, Radiation Medicine & Applied Sciences, UC San Diego
Dr. Moore is the Deputy Director of the Medical Physics Division and the RMAS Assistant Vice-Chair for Physics & Technology Research. He is also the Director of the Center for Quality, Innovation, Value and Efficiency in Radiotherapy (QUIVER). Knowledge-based planning involves applying prior knowledge from large datasets of previously treated patients in order to optimize treatment planning of new patients, significantly improving plan quality and efficiency. He is currently engaged in both the development of new knowledge-based dose prediction methods as well as the clinical implementation of knowledge-based radiotherapy treatment planning across the UC San Diego enterprise.
Dr. Moore has successfully applied this approach to a wide variety of radiotherapy treatment sites, including head-and-neck, prostate, gynecologic, brain, lung, pancreas, bone, anorectal, and liver cancers. He has published 40 peer-reviewed papers and book chapters, and is lead inventor on two patents regarding knowledge-based dosimetric prediction. His other research interests are focused on the expansion of data-driven methods in radiotherapy, particularly creating efficient decision support systems and the use of application programming interfaces (APIs) to automate error-prone and inefficient clinical processes. He is overseeing the technical implementation of the Ethos Accelerator and the work flow processes for adaptive radiotherapy.
Dr. Moore is a lecturer and mentor in the UCSD physics and physician residencies. He is also an active clinical medical physicist focused on external beam radiotherapy.
Arno J. Mundt, MD, FASTRO, FACRO
Chair, Radiation Medicine & Applied Sciences, UC San Diego
Dr. Arno J. Mundt is a Professor and Founding Chair of the Department of Radiation Medicine and Applied Sciences (RMAS) and also a member of the Executive Governing Committee of the Moores NCI-Designated Comprehensive Cancer Center.
An internationally-recognized academic radiation oncologist whose career has focused on the development and implementation of novel radiation technologies in a wide number of malignancies, he is an author of over 200 journal articles and book chapters, predominantly focused on advanced radiation technologies, Dr. Mundt has edited 3 academic textbooks, two devoted to intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT) with over 100 contributors from the United States, Canada, Europe and Asia. He has delivered over 250 invited lectures at cancer symposia and conferences throughout the United States, Europe, South America and Asia, and has been a Visiting Professor at over 30 Universities and Cancer Centers.
Dr. Mundt has been recognized with numerous awards and accolades over his career, including being named a Fellow of the American College of Radiation Oncology (ACRO) and the American Society for Radiation Oncology (ASTRO) as well as a Top Doctor by the Chicago and San Diego Magazines multiple times. He has been an invited speaker at over 200 seminars, symposia and workshops in the United States and abroad. He has received a Career Achievement Award from the Radiating Hope Organization and currently serves on the Radiating Hope Board of Trustees. A former ACRO President and Board Chair, he received the ACRO Gold Medal in 2017. He has been on multiple Editorial Boards including serving as Senior Editor (Gynecology) of the International Journal of Radiation Oncology, Biology and Physics as well as Section Editor for Up-To-Date; he is also on the Board of Directors of multiple charity organizations including Radiating Hope, Cure Cervical Cancer Foundation, and the Canines-N-Kids Foundation.
Xenia Ray, PhD
Assistant Professor, Radiation Medicine & Applied Sciences, UC San Diego
Dr. Xenia Ray is an Assistant Professor and a member of the La Jolla Physics Team. A research-focused Physicist, she is the Associate Director of Adaptive Radiotherapy in the Center for Quality, Innovation, Value and Efficiency in Radiotherapy (QUIVER).
Her research interests are focused on using the volumes of data generated by cancer centers to inform important clinical decisions surrounding patient care. Past projects included using radiomics features extracted from computed tomography images to predict non-small cell lung cancer outcomes, developing metrics to evaluate the performance of publicly available knowledge-based treatment models, and investigating the sensitivity of transit images to detect changes during treatment. She is currently developing an automated batch-processing framework to investigate the dosimetric gains possible with daily adaptive planning. This framework will provide quantitative data for when and how plans should be adapted using routinely acquired CBCT imaging, automated segmentation, and knowledge-based planning.
Dr. Ray is also an active clinical medical physicist in both external beam radiotherapy and brachytherapy. She is the Gastrointestinal (GI) Tumor Technology Section Chief and has an expanding role in resident education as a UCSD lecturer and rotation mentor.
About the Location
San Diego provides an ideal environment for successful partnerships and collaborations: The intersection of academia, biomedical research, top-notch health care providers, and entrepreneurship allow innovation to abound. San Diego’s position as a global hub for biomedical innovation serves as a role model for translational oncology on a national level.
Please use the following booking links in order to secure the UC San Diego rate at these local hotels: